CLASS III Drug recall · Reported 16 Nov 2016 · FDA Enforcement Report
Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network recalled
Wells Pharmacy Network is recalling Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network. The recall was initiated on 19 Sep 2016 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0129-2017
- FDA event ID
- 75247
- Recalling firm
- Wells Pharmacy Network, Dyersburg, TN
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 19 Sep 2016
- FDA classified
- 8 Nov 2016
- Reported
- 16 Nov 2016
- Type
- Voluntary: Firm initiated
- Customers notified by
- Telephone
- Reason category
- Potency & Assay
- Drug class
- Hormones & Birth Control
Timeline
| 19 Sep 2016 | Recall initiated by company | |
| 8 Nov 2016 | Classified by FDA | +50 days |
| 16 Nov 2016 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Superpotent and Subpotent drugs
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network
Where it was distributed
U.S.
Questions about this recall
Why was it recalled?
Superpotent and Subpotent drugs
Which lots are affected?
Lot Number 08052016@3, BUD 02/01/2017
Where was it sold?
U.S.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
6 other products · FDA event 75247This product is part of a recall event; the main page for the event is Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded recalled.
More recalls from Wells Pharmacy Network
All 104| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Alprostadil 40 mcg/mL Injectable vials recalled | Wells Pharmacy Network | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Enanthate in Grapeseed Oil Injectable recalled | Wells Pharmacy Network | Sterility | Nationwide |
| Drug | CLASS II | QUAD2 (Pap/Phen/Alpros/Atro) 9 mg/1 mg/10 mg/0.1 mg/mL recalled | Wells Pharmacy Network | Sterility | Nationwide |
| Drug | CLASS II | Trimix Injectable 30 mg/3 mg/60 mcg/mL, a), b) and c) vials recalled | Wells Pharmacy Network | Sterility | Nationwide |
| Drug | CLASS II | Methylcobalamin Injectable (Dr. Hall Kit) recalled | Wells Pharmacy Network | Sterility | Nationwide |
Other Testosterone Pellet recalls
All 29| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Testosterone 200 mg Pellet recalled by Qualgen | Qualgen | Packaging Defects | Nationwide |
| Drug | CLASS II | Testosterone 12.5mg pellet recalled by Qualgen | Qualgen | Sterility | Nationwide |
| Drug | CLASS II | Testosterone 87.5mg pellet recalled by Qualgen | Qualgen | Sterility | Nationwide |
| Drug | CLASS II | Testosterone 200mg pellet recalled by Qualgen | Qualgen | Sterility | Nationwide |
| Drug | CLASS II | Testosterone 37.5 mg pellet recalled by Qualgen | Qualgen | Sterility | Nationwide |